{"id":"W2794378246","doi":"10.2147/dddt.s130809","title":"Rucaparib: a novel PARP inhibitor for <em>BRCA</em> advanced ovarian cancer","year":2018,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"PARP inhibitor; Ovarian cancer; Cancer research; Medicine; Poly ADP ribose polymerase; Chemistry; Pharmacology; Cancer; Internal medicine; Biochemistry; DNA; Polymerase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.002106494,0.002070135,0.004070671,0.0008619952,0.0007184327,0.0002935382,0.0006953277,0.001019598,0.0008414518],"category_scores_gemma":[0.0001160041,0.001719053,0.0008213613,0.001088449,0.0003497441,0.0003362486,0.0001337883,0.0008691197,0.0002746584],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001213836,"about_ca_system_score_gemma":0.003912806,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001502683,"about_ca_topic_score_gemma":0.0001381522,"domain_scores_codex":[0.9921333,0.0003540996,0.002456389,0.002164615,0.001279944,0.001611618],"domain_scores_gemma":[0.99506,0.0006953867,0.001421097,0.001311708,0.0007529686,0.0007588478],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001503799,0.0005456718,0.00001599402,0.004501616,0.002303943,0.00001482532,0.005527198,0.000002259548,0.001427691,0.0002535937,0.03922874,0.9446747],"study_design_scores_gemma":[0.00966324,0.0002377294,0.00002338625,0.01415059,0.0005056446,0.0001122926,0.00006424277,0.000006321678,0.001652137,0.0003634676,0.9712301,0.001990829],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0008782032,0.9626936,0.0246221,0.0004677256,0.002600608,0.007617833,0.0002853411,0.0004405814,0.0003940289],"genre_scores_gemma":[0.00006040504,0.8894089,0.08951828,0.001418294,0.002415263,0.006431799,0.001137345,0.0005048276,0.009104894],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9426838,"threshold_uncertainty_score":0.999204,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1120232755198394,"score_gpt":0.3535853993551428,"score_spread":0.2415621238353035,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}